Amdocs Limited

As of June 30, 2026, Amdocs Limited carries a market capitalization of 5.28B, placing it among publicly traded companies globally. Its enterprise value stands at 6.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Amdocs Limited's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Amdocs Limited has 104.42M shares outstanding.

As of June 30, 2026, Amdocs Limited trades at a trailing price-to-earnings ratio of 11.91. The price-to-sales ratio is 1.16, and the price-to-book ratio stands at 1.61.

As of June 30, 2026, Amdocs Limited trades at an EV/EBITDA multiple of 7.42 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.89 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Amdocs Limited trades at an EV/FCF ratio of 7.89, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 6.20B versus a market cap of 5.28B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Amdocs Limited maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.67, indicating elevated leverage, while an interest coverage ratio of 17.72 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Amdocs Limited posted a return on equity (ROE) of 13.37, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.12 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.12, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.07, useful for judging operating efficiency across full business cycles. The company generates approximately 172,532.57 in revenue per employee across its workforce of 26,969.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Amdocs Limited recorded 126.01M in income tax expense. That works out to an effective tax rate of 21.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 583.55M, leaving 453.88M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Amdocs Limited's stock has declined approximately 24.17% over the past 52 weeks. The 50-day moving average sits at 60.17, while the 200-day moving average is 63.24.

Over the twelve months ended June 30, 2026, Amdocs Limited generated 4.65B in revenue and converted that into 453.88M in net income, yielding earnings per share of 4.22. EBITDA reached 835.86M, while operating income came in at 828.59M.

As of June 30, 2026, Amdocs Limited holds 206.45M in cash and equivalents against 1.09B in total debt, resulting in a net debt position of 720.92M. Total book value stands at 3.29B, with working capital of -109.73M providing operational flexibility.

Amdocs Limited produced 748.82M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Amdocs Limited posted a gross margin of 38.28, reflecting its pricing power and cost economics. The operating margin of 17.81 and net profit margin of 9.75 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Amdocs Limited paid dividends of 2.17 per share. The dividend payout ratio of 50.36 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 13.67, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.38, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Amdocs Limited shareholders.